Skip to main content
. 2013 Jul 29;8(7):e69613. doi: 10.1371/journal.pone.0069613

Figure 5. Hematological toxicity.

Figure 5

The ratio of platelets number between treated mice and controls was monitored at various times (0–30 d) after treatment with (A) 212Pb-PX (non-specific), (B) 212Pb-35A7 (anti-CEA) and (C) 212Pb-Trastuzumab (anti-HER2 mAbs).